Access Statistics for Matthew J. Higgins

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
A Country‑Specific View of Tariffs 0 9 13 13 6 17 20 20
Accounting for Price Endogeneity in Airline Itinerary Choice Models: An Application to Continental U.S. Markets 0 0 0 46 4 6 9 93
Assets with "Warts": How Reliable is the Market for Technology? 0 0 0 8 0 2 3 40
Behind the Scenes: Sources of Complementarity in R&D 0 0 0 16 5 7 8 83
Black Populations and Economic Growth: An Extreme Bounds Analysis of Mississippi County-Level Data 0 0 0 37 3 10 13 268
Blockbusters, Sequels and the Nature of Innovation 1 1 14 14 4 13 33 33
Conveying Quality and Value in Emerging Industries: Star Scientists and the Role of Learning in Biotechnology 0 0 0 34 5 8 8 229
Corporate Venture Capital as a Real Option in the Markets for Technology 0 0 0 71 4 6 7 108
Don’t Throw the Baby Out With the Bathwater: Firm Response to Downstream Product Shocks 0 0 2 18 1 4 14 32
Explaining Preferences for Control Rights in Strategic Alliances: A Property Rights and Capabilities Perspective Approach 0 0 0 29 2 7 10 86
Federal, State, and Local Governments: Evaluating their Separate Roles in US Growth 0 0 0 61 2 5 8 431
Federal, State, and Local Governments: Evaluating their Separate Roles in US Growth 0 0 0 47 3 5 14 375
Federal, State, and Local Governments:Evaluating their Separate Roles in US Growth 0 0 0 12 3 6 6 148
Federal, state, and local governments: evaluating their separate roles in US growth 0 0 1 4 4 10 16 50
Generic Competition and the Incentives for Early-Stage Pharmaceutical Innovation 0 0 1 41 5 12 24 118
Growth and Convergence across the U.S: Evidence from County-Level Data 0 0 1 255 16 19 23 782
Growth and Convergence across the US: Evidence from County-Level Data 0 0 0 7 7 9 10 107
Growth and Convergence across the US: Evidence from County-Level Data 0 0 0 204 8 14 23 639
Growth and Convergence across the US: Evidence from County-Level Data 0 0 2 15 5 9 15 185
Growth and Convergence across the United States: Evidence from County-Level Data 0 0 0 2 6 8 14 32
Heterogeneity in Convergence Rates and Income Determination across U.S. States: Evidence from County-Level Data 0 0 0 209 4 6 7 1,135
Heterogeneity in Convergence Rates and Income Determination across U.S. States: Evidence from County-Level Data 0 0 0 2 1 3 6 101
Heterogeneous Convergence 0 0 0 57 5 9 11 214
Heterogeneous Convergence 0 0 0 14 12 14 15 107
Heterogeneous Convergence 0 0 0 15 7 12 14 107
Heterogeneous Convergence 0 0 1 39 6 11 14 346
Heterogeneous convergence 0 0 0 2 3 9 14 41
Intra-alliance performance, control rights, and today's split of tomorrow's value 0 0 0 85 7 9 10 235
Many Types of Human Capital and Many Roles in U.S. Growth: Evidence from County-Level Educational Attainment Data 0 0 2 426 2 6 18 3,824
Many Types of Human Capital and Many Roles in U.S. Growth: Evidence from County-Level Educational Attainment Data 0 0 0 11 2 5 11 128
Market Size and Research: Evidence from the Pharmaceutical Industry 0 0 0 17 2 4 5 58
Moving Beyond the Valley of Death: Regulation and Venture Capital Investments in Early-Stage Biopharmaceutical Firms 0 0 0 42 3 6 6 67
Pediatric Drug Adherence and Parental Attention: Evidence from Comprehensive Claims Data 0 0 0 1 1 4 7 17
Regulation and Welfare: Evidence from Paragraph IV Generic Entry in the Pharmaceutical Industry 0 0 0 57 5 10 14 281
Research and Market Structure: Evidence from an Antibiotic-Resistant Pathogenic Outbreak 0 0 0 2 5 8 9 24
Robust Correlates of County-Level Growth in the U.S 0 1 1 40 6 9 16 186
Robust correlates of county-level growth in the United States 0 0 0 0 3 4 6 18
Sigma Convergence Versus Beta Convergence: Evidence from U.S. County-Level Data 0 0 0 30 1 4 11 135
Sigma Convergence Versus Beta Convergence: Evidence from U.S. County-Level Data (revised version) 0 0 1 36 2 3 6 131
Sigma Convergence versus Beta Convergence: Evidence from U.S. County-Level Data 0 0 1 151 4 9 12 540
Sigma Convergence versus Beta Convergence: Evidence from U.S. County-Level Data 0 0 0 1 5 9 10 29
Sigma-Convergence Versus Beta-Convergence: Evidence from U.S. County-Level Data 0 0 0 522 3 4 5 1,668
Stronger IPR, Better Inclusion? Impact Of WTO Accession On Female AI Inventors in China 0 0 2 14 2 3 10 44
The Direct and Indirect Effects of Small Business Administration Lending on Growth: Evidence from U.S. County-Level Data 0 0 0 56 4 6 9 162
The Direct and Indirect Effects of Small Business Administration Lending on Growth: Evidence from U.S. County-Level Data 0 0 0 46 4 9 12 122
The Effect of Contractual Complexity on Technology Sourcing Agreements 0 0 0 40 1 2 3 262
The Impact of Patenting on New Product Introductions in the Pharmaceutical Industry 0 0 0 120 3 4 7 397
The Role of Assets In Place: Loss of Market Exclusivity and Investment 0 0 0 11 7 9 12 47
Unpacking the effects of adverse regulatory events: Evidence from pharmaceutical relabeling 0 0 0 14 1 4 6 55
Why Investment‑Led Growth Lowers Chinese Living Standards 0 0 2 17 4 9 18 29
Will Peak Demand Roil Global Oil Markets? 0 0 3 3 1 5 6 6
Total Working Papers 1 11 47 3,014 209 386 588 14,375


Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Accounting for price endogeneity in airline itinerary choice models: An application to Continental U.S. markets 0 1 3 9 1 4 11 82
Behind the Scenes: Sources of Complementarity in R&D 0 0 0 6 7 11 16 69
Conveying quality and value in emerging industries: Star scientists and the role of signals in biotechnology 0 0 0 24 8 11 18 172
Corporate venture capital as a real option in the markets for technology 0 0 0 6 6 10 17 59
Evaluating the effects of Small Business Administration lending on growth 1 1 6 15 4 9 21 81
Federal, State, and Local Governments: Evaluating Their Separate Roles in US Growth 0 0 1 2 7 11 15 39
Federal, state, and local governments: evaluating their separate roles in US growth 0 0 0 32 4 7 14 194
Generic competition and the incentives for early-stage pharmaceutical innovation 0 1 4 7 3 10 18 32
Growth and Convergence across the United States: Evidence from County-Level Data 0 0 0 4 5 7 9 37
Growth and Convergence across the United States: Evidence from County-Level Data 0 1 2 154 7 14 23 431
Heterogeneous Convergence 0 0 0 3 5 9 10 40
Heterogeneous convergence 0 0 0 40 8 10 14 152
How Reliable Is the Market for Technology? 0 0 0 14 0 2 6 77
Modeling competition among airline itineraries 1 1 2 13 3 6 11 63
Pediatric Drug Adherence and Parental Attention: Evidence From Comprehensive Claims Data 0 0 0 0 6 6 6 6
Productivity and the role of complementary assets in firms' demand for technology innovations 0 0 0 23 6 7 9 118
Regulation and welfare: evidence from paragraph IV generic entry in the pharmaceutical industry 0 0 0 11 2 3 4 78
Research and market structure: Evidence from an antibiotic-resistant pathogenic outbreak 0 0 0 0 2 7 12 15
Robust Correlates of County-Level Growth in the U.S 0 0 0 0 2 9 11 60
Robust correlates of county-level growth in the United States 0 0 0 11 2 4 5 55
Sigma Convergence versus Beta Convergence: Evidence from U.S. County-Level Data 0 0 4 11 7 12 19 54
Sigma Convergence versus Beta Convergence: Evidence from U.S. County-Level Data 0 0 0 293 0 2 10 1,185
Sigma Convergence versus Beta Convergence: Evidence from U.S. County‐Level Data 0 0 2 10 0 3 12 48
Strategic Alliances: Trading Ownership for Capabilities 0 0 0 8 2 7 10 50
The allocation of control rights in pharmaceutical alliances 0 0 0 60 0 2 3 167
The balance of payments crisis in the euro area periphery 0 1 3 180 4 10 27 716
The impact of advance purchase deadlines on airline consumers’ search and purchase behaviors 0 0 1 8 2 3 7 62
The outsourcing of R&D through acquisitions in the pharmaceutical industry 1 1 10 374 5 9 33 1,044
Unpacking the effects of adverse regulatory events: Evidence from pharmaceutical relabeling 0 1 1 4 2 4 8 24
Total Journal Articles 3 8 39 1,322 110 209 379 5,210


Statistics updated 2026-02-12